Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.

Publikation

Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.

Wissenschaftlicher Artikel/Review - 17.07.2023

RAF and RENO-EXTEND Investigators*, Dittrich Tolga

Zitation

RAF and RENO-EXTEND Investigators*, Dittrich T. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy. Eur Stroke J 2023:23969873231183211.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Eur Stroke J 2023

Veröffentlichungsdatum

17.07.2023

eISSN (Online)

2396-9881

Seiten

23969873231183211

Kurzbeschreibung/Zielsetzung

Ischaemic stroke patients with atrial fibrillation (AF) are at high risk of stroke recurrence despite oral anticoagulation therapy. Patients with cardiovascular comorbidities may take both antiplatelet and oral anticoagulation therapy (OAC/AP). Our study aims to evaluate the safety and efficacy of OAC/AP therapy as secondary prevention in people with AF and ischaemic stroke.